A desperate deal by Genprex could spell opportunity for investors. Here's how.
Let's review PENN's charts and indicators.
The stock looks ready for further gains after sprinting higher from a small double-bottom in March/April.
Support and resistance levels for the major equity benchmarks.
Anyone attempting to navigate this market based on macro-economic analysis is going to have a tough time.
The truly impressive performance metrics are some of the same lines that impressed me so much at Walmart.
GME has had a rough run in recent years due to declining revenue and changes in the gaming markets.
It's time for greater recognition of Taiwan as the independent state that it is, and time to push China on that front instead of trade.
Our latest analysis and strategy for trading FB shares.
Bausch Health and Greenbrier Cos. have seen large chunks of their shares bought recently by people close to the companies.